醫學生物學研究領域 2017

Hsiao, Michael

  • Wang CK, Yang SC, Hsu SC, Chang FP, Lin YT, Chen SF, Cheng CL, Hsiao M, Lu FL, Lu J, 2017, “CHAC2 is essential for self-renewal and glutathione maintenance in human embryonic stem cells.”, Free Radical Biology & Medicine, 113, 439-451. (SCIE)
  • Li HY, Liang JL, Kuo YL, Lee HH, Calkins MJ, Chang HT, Hsu TI, Shen YR, Hsiao M, Ger LP, Lu PJ, 2017, “miR-105/93-3p promotes chemosresistance and circulating miR-105/93-3p acts as a diagnostic marker for triple negative breast cancer”, Breast Cancer Research, 19(1), 133. (SCIE)
  • Yeh CN, Chang YC, Su Y, Hsu DS, Cheng CT, Wu RC, Chung YH, Chiang KC, Yeh TS, Lu ML, Liu CY, Chang PM, Chen MH, Huang CY, Hsiao M*, Chen MH, 2017, “Upregulation of MALT1 determines poor clinical outcomes in cholangiocarcinoma and shows therapeutic potential of regorafenib”, Oncotarget, 8(69), 113444-113459.
  • Huang SP, Chang YC, Low QH, Wu ATH, Chen CL, Lin YF, Hsiao M*, 2017, “BICD1 expression, 1 as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas”, Oncotarget, 8(69), 113766-113791.
  • Cheng PW, Lin YT, Ho WY, Lu PJ, Chen HH, Lai CC, Sun GC, Yeh TC, Hsiao M, Tseng CJ, Liu CP, 2017, “Fructose induced neurogenic hypertension mediated by overactivation of p38 MAPK to impair insulin signaling transduction caused central insulin resistance.”, Free Radical Biology & Medicine, Nov;112, 298-307. (SCIE)
  • Lo A, Li CP, Buza EL, Blomberg R, Govindaraju P, Avery D, Monslow J, Hsiao M, Pure E, 2017, “Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma”, JCI Insight, 2(19), pii: 92232. (SCIE)
  • Hua KT, Chien MH, Lee WJ, Yang YC, Lin YL, Chen BR, Cheng TY, Yang PW, Wang MY, Jan YH, Lee JM, Hsiao M, Chen JS, 2017, “KSRP suppresses cell invasion and metastasis through miR-23a-mediated EGR3 mRNA degradation in non-small cell lung cancer”, BiochimicaI et Biophysica Acta-Gene Regulatory Mechanisms, 1860(10), 1013-1024.
  • Chang JH, Lai SL, Chen WS, Hung WY, Chow JM, Hsiao M, Lee WJ, Chien MH, 2017, “Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways.”, Biochimica et Biophysica Acta-Molecular Cell Research, 1864(10), 1746-1758. (SCIE)
  • Chang YC, Chan YC, Chang MW, Lin YF, Yang CJ, Su CY, Huang MS, Wu AT, Hsiao M*, 2017, “Feedback regulation of ALDOA activates HIF-1α/MMP9 axis to promote lung cancer progression”, Cancer Letters, 403, 28-36, Cite 21. (SCIE)
  • Chan YC, Hsiao M*, 2017, “Protease-activated nanomaterials for targeted cancer theranostics”, Nanomedicine, 12(18), 2153-2159. (SCIE) (IF: 4.3; SCI ranking: 19.2%,41.7%)
  • Chen ST, Li FJ, Hsu TY, Liang SM, Yeh YC, Liao WY, Chou TY, Chen NJ, Hsiao M, Yang WB, Hsieh SL*, 2017, “CLEC5A is a critical receptor in innate immunity against Listeria infection.”, Nature Communications, 8(1), 299. (SCIE)
  • Chiou J, Su CY, Jan YH, Yang CJ, Huang MS, Yu YL, Hsiao M*, 2017, “Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma”, Scientific Reports, 7(1), 9830. (SCIE)
  • Lin TC, Hsiao M*, 2017, “Ghrelin and cancer progression”, Biochimica et Biophysica Acta-Reviews on Cancer, 1868, 51-57, Cite 23. (SCIE)
  • Chi LH, Chang YC, Chang WM, Chan YC, Tai CC, Leung KW, Chen CL, Wu ATH, Lai TC, Li YCJ Li, Hsiao M*., 2017, “Global proteomics-based Identification and validation of Thymosin Beta-4 2 X-Linked as a prognostic marker for head and neck squamous cell carcinoma”, Scientific Reports, 7(1), 9031. (SCIE)
  • Hsiao YW, Lai TC, Lin YH, Su CY, Liao AT, Lin YF, Hsieh SC, Wu AT, Hsiao M*, 2017, “Granulysin expressed in a humanized mouse model induces apoptotic cell death and suppresses tumorigenicity”, Oncotarget, 8(48), 83495-83508.
  • Chang YC, Su CY, Chen MH, Chen WS, Chen CL, Hsiao M*, 2017, “Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promotes colon cancer metastasis and is associated with poor prognosis”, Molecular Cancer, 16(1), 135, Cite 12. (SCIE)
  • Su YK, Shih PH, Lee WH, Bamodu OA, Wu ATH, Huang CC, Tzeng YM, Hsiao M, Yeh CT, Lin CM, 2017, “Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression.”, Journal of Ethnopharmacology, 207, 47-56. (SCIE)
  • Lin YT, Wang CK, Yang SC, Hsu SC, Lin H, Chang FP, Kuo TC, Shen CN, Chiang PM, Hsiao M, Lu FL, Lu J, 2017, “Elimination of undifferentiated human embryonic stem cells by cardiac glycosides.”, Scientific Reports, 7(1), 5289. (SCIE)
  • Liu CW, Hua KT, Li KC, Jeng YM, Kao HF, Hong RL, Ko JY, Hsiao M, Kuo ML, Tan CT, 2017, “Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate-cysteine ligase catalytic subunit in head and neck squamous cell carcinoma”, Molecular Cancer Therapeutics, Jul;16(7), 1421-1434. (SCIE)
  • Hua KT, Liu YF, Hsu CL, Cheng TY, Yang CY, Chang JS, Lee WJ, Hsiao M, Juan HF, Chien MH, Yang SF, 2017, “3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma”, Scientific Reports, 7(1), 4466. (SCIE)
  • Liu M, Bamodu OA, Huang WC, Zucha MA, Lin YK, Wu AT, Huang CC, Lee WH, Yuan CC, Hsiao M, Deng L, Tzeng YM, Yeh CT, 2017, “4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.”, Toxicology and Applied Pharmacology, Jun 15;325, 48-60. (SCIE)
  • Chien MH, Lee WJ, Chang YC, Chang WM, Lai TC, Chan DV, Sharma R, Lin YF, Hsiao M*, 2017, “A Fas ligand (FasL)-fused humanized antibody against tumor-associated glycoprotein 72 (hcc49scFV-FasL) selectively exhibits the cytotoxic effect against oral cancer cells with a low FasL/Fas ratio”, Molecular Cancer Therapeutics, 16(6), 1102-1113, Cite 5. (SCIE)
  • Lin YC, Hwu YK, Huang GS, Hsiao M, Lee TT, Yang SM, Yang SS, Ka SM, Chen A, 2017, “Differential synchrotron X-ray imaging markers based on the renal microvasculature for tubulointerstitial lesions and glomerulopathy”, Scientific Reports, 7(1), 3488. (SCIE)
  • Chan MH, Pan YT, Lee IJ, Chen CW, Chan YC, Hsiao M*, Wang F, Sun L, Chen X, Liu RS, 2017, “Minimizing the heat effect of photodynamic therapy based on inorganic nanocomposites mediated by 808 nm near-infrared light”, Small, 13(21), 1700038, Cite 44. (SCIE)
  • Chen YC, Li HY, Liang JL, Hsiao M, Chuang JH, Lu PJ, 2017, “CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient”, Oncotarget, May 2;8(18), 29699-29710.
  • Chen WM, Yang ST, Chien MH, Hua KT, Wu CJ, Hsiao SM, Hsiao M, Kuo ML, Su JL, Wei LH, 2017, “The STAT3/miRNA-92/wnt signaling pathway regulates ovarian cancer spheroids and tumor progression”, Cancer Research, Apr 15;77(8):, 1955-1967. (SCIE)
  • Chiang KC, Yeh TS, Huang CC, Chang YC, Juang HH, Chang CT, Pang JH, Chang JT, Takano M, Chen TC, Kittaka A, Hsiao M*, Yeh CN, 2017, “MART-10, the vitamin D analog, represses cholangiocarcinoma cell growth and high vitamin D receptor expression is linked with better prognosis for cholangiocarcinoma patients”, Scientific Reports, 7, 43773. (SCIE)
  • Hou KL, Lin SK, Chao LH, Lai EH, Chang CC, Shun CT, Lu WY, Wang JH, Hsiao M, Hong CY, Kok SH, 2017, “Sirtuin 6 suppresses hypoxia-induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis - A therapeutic implication in inflammatory bone resorption”, BioFactors, 43(2), 170-180. (SCIE)
  • Chien MH, Lee TH, Lee WJ, Yeh YH, Li TK, Wang PC, Chen JJ, Chow JM, Lin YW, Hsiao M, Wang SW, Hua KT, 2017, “Trichodermin induces c-Jun N-terminal kinase-dependent apoptosis caused by mitotic arrest and DNA damage in human p53-mutated pancreatic cancer cells and xenografts ”, Cancer Letters, 388, 249-261. (SCIE)
  • Lee YC, Su CY, Lin YF, Lin CM, Fang CY, Lin YK, Hsiao M*, Chen CL, 2017, “Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but associated with better survival in patients receiving colorectal cancer chemotherapy”, Oncotarget, 8(7), 12120-12132.
  • Huang YJ, Yang CK, Wei PL, Huynh TT, Whang-Peng J, Meng TC, Hsiao M, Tzeng YM, Wu AT, Yen Y, 2017, “Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.”, Journal of Hematology & Oncology, 10(1), 60. (SCIE)
  • Chang YC, Chi LH, Chang MW, Su CY, Lin YF, Chen CL, Chen MH, Chang PM, Wu AT, Hsiao M*, 2017, “Glucose transporter 4 promotes head and neck cancer metastasis through TRIM24-DDX58 axis”, Journal of Hematology & Oncology, 10(1), 11, Cite 10. (SCIE)
  • Hsieh CC, Shyr YM, Liao WY, Chen TH, Wang SE, Lu PC, Lin PY, Hsiao M, Li WS, Sher YP, Shen CN*, 2017, “Modulation of β-galactoside α2,6-sialyltranferase 1 in a fructose-responsive manner promotes pancreatic cancer metastasis”, Oncotarget, 8(5), 7691-7709.
  • Chang WM, Lin YF, Su CY, Peng HY, Chang YC, Hsiao JR, Chen CL, Chang JY, Shieh YS, Hsiao M, Shiah SG, 2017, “Parathyroid hormone-like hormone is a poor prognosis marker of head and neck cancer and promotes cell growth via RUNX2 regulation”, Scientific Reports, 7, 41131. (SCIE)

Hsieh, Shie-Liang

  • Lee PC, Yang LY, Wang YW, Huang SF, Lee KC, Hsieh YC, Yang YY, Hsieh SL, Hou MC, Lin HC, Lee FY, Lee SD*, 2017, “Mechanisms of the prevention and inhibition of the progression and development of NASH by genetic and pharmacological DcR3 supplementation.”, HEPATOLOGY RESEARCH, 47(12), 1260-1271. (SCIE)
  • Cheng AC, Yang KY, Chen NJ, Hsu TL, Jou R, Hsieh SL, Tseng PH*, 2017, “CLEC9A modulates macrophage-mediated neutrophil recruitment in response to heat-killed Mycobacterium tuberculosis H37Ra”, PLoS One, 12(10), e0186780. (SCIE)
  • Chen ST, Chen JW, Wu WC, Chou TY, Yang CY, Hsieh SL*, 2017, “CLEC5A is a critical receptor in innate immunity against Listeria infection”, NATURE COMMUNICATIONS, 8(1):299. (SCIE)
  • Li TH, Liu CW, Lee PC, Huang CC, Lee KC, Hsieh YC, Yang YY, Hsieh SL, Lin HC, Tsai CY*, 2017, “Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injury”, JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 80(7), 391-400. (SCIE)
  • Chiu CW, Cheng H, Hsieh SL*, 2017, “Contusion spinal cord injury rat model”, Bio-protocol, 7(12): DOI: 10.21769/BioProtoc.2337.
  • Hsieh SL*, Lin WW*, 2017, “Decoy receptor 3: An endogenous immunomodulator in cancer growth and inflammatory reactions”, JOURNAL OF BIOMEDICAL SCIENCE, 24(1), 39. (SCIE)
  • Liu YL, Chen WT, Lin YY, Lu PH, Hsieh SL*, Cheng, IH*, 2017, “Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model”, MOLECULAR NEURODEGENERATION, 12(1), 1-17. (SCIE)
  • Lai JH, Lin YL, Hsieh SL* , 2017, “Pharmacological intervention for dengue virus infection”, BIOCHEMICAL PHARMACOLOGY, 129, 14-25. (SCIE)
  • Wen KC, Sung PL, Hsieh SL, Chou YT, Lee OK, Wu CW, Wang PH*, 2017, “α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells.”, ONCOTARGET, 8(17), 29013-29027.
  • Teng, O, Chen, ST, Hsu TL, Sia SF, Cole S, Valkenburg SA, Hsu TY, Zheng JT, Tu W, Bruzzone R, Peiris JSM, Hsieh SL*, Yen HL*, 2017, “CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo.”, JOURNAL OF VIROLOGY, 91(1), e01813-e01816. (SCIE)
  • Chen MH, Kan HT, Liu CY, Yu WK, Lee SS, Wang JH, Hsieh SL*, 2017, “Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients”, JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 116(1), 49-56. (SCIE)

Hwang-Verslues, Wendy W.

  • Huang S.-C., Wei P.-C., Hwang-Verslues W.W., Kuo W.-H., Jeng Y.-M., Hu C.-H., Shew J.-Y., Huang C.-S., Chang K.-J., Lee E. Y.-H. P., Lee W.-H.*, 2017, “TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB”, EMBO MOLECULAR MEDICINE, 9(12), 1660-1680. (SCIE)

Lee, Wen-Hwa

  • Huang SC, Wei PC, Hwang-Verslues WW, Kuo WH, Jeng YM, Hu CM, Shew JY, Huang CS, Chang KJ, Lee EY, Lee WH, 2017, “TGF-beta1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.”, EMBO molecular medicine, 9(12), 1660-1680. (SCIE)
  • Huang CK, Chang PH, Kuo WH, Chen CL, Jeng YM, Chang KJ, Shew JY, Hu CM, Lee WH, 2017, “Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via beta-hydroxybutyrate.”, Nature communications, 8, 14706. (SCIE)

Lin, Kuo-I

  • Wu, J.-L., Chiang, M.-F., Hsu, P.-H., Tsai, D.-Y., Hung, K.-H., Wang, Y.-H., Angata, T.* and Lin, K.-I*, 2017, “O-GlcNAcylation is required for B cell homeostasis and antibody responses”, NATURE COMMUNICATIONS, 8(1):1854. (SCIE)
  • Lai, C.-Y., Su, Y.-W., Lin, K.-I, Hsu, L.-C. and Chuang, T.-H., 2017, “Natural modulators of endosomal Toll-like receptor-mediated psoriatic skin inflammation”, Journal of Immunology Research, 10.1155/2017, 7807313. (SCIE)

Lu, Joyce Jean

  • Wang CK, Yang SC, Hsu SC, Chang FP, Lin YT, Chen SF, Cheng CL, Hsiao M, Lu FL, Lu J*, 2017, “CHAC2 is essential for self-renewal and glutathione maintenance in human embryonic stem cells.”, Free radical biology & medicine, 113, 439-451. (SCIE)
  • Lai PL, Lin H, Chen SF, Yang SC, Hung KH, Chang CF, Chang HY, Lu FL, Lee YH, Liu YC, Huang HC*, Lu J*, 2017, “Efficient Generation of Chemically Induced Mesenchymal Stem Cells from Human Dermal Fibroblasts.”, Scientific reports, 7, 44534. (SCIE)
  • Lin YT, Wang CK, Yang SC, Hsu SC, Lin H, Chang FP, Kuo TC, Shen CN, Chiang PM, Hsiao M, Lu FL, Lu J*, 2017, “Elimination of undifferentiated human embryonic stem cells by cardiac glycosides.”, Scientific reports, 7(1), 5289. (SCIE)
  • Kuan II, Liang KH, Wang YP, Kuo TW, Meir YJ, Wu SC, Yang SC, Lu J*, Wu HC*, 2017, “EpEX/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2alpha.”, Scientific reports, 7, 41852. (SCIE)
  • Hsieh MH, Chen YT, Chen YT, Lee YH, Lu J, Chien CL, Chen HF, Ho HN, Yu CJ, Wang ZQ, Teng SC, 2017, “PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cells.”, Nucleic acids research, 45(18), 10492-10503. (SCIE)

Shen, Chia-Ning

  • W.C. Yang, Y.S. Hwang, Y.Y. Chen, C.L. Liu, C.N. Shen, W.H. Hong, S.M. Lo, C.R. Shen, 2017, “Interleukin-4 supports the suppressive immune responses elicited by regulatory T cells”, Frontiers in Immunology, 8, 1508. (SCIE)
  • C.L. Hsieh, C.M. Liu, H.A. Chen, S.T. Yang, K. Shigemura, K. Kitagawa, F. Yamamichi, M. Fujisawa, Y.R. Liu, W.H. Lee, K.C. Chen, C.N. Shen, C.C. Lin, L. Chung and S.Y. Sung., 2017, “Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression.”, Scientific reports, 7(1), 9065. (SCIE)
  • Y.T. Lin, C.K. Wang, S.C. Yang, S.C. Hsu, H. Lin, F.P. Chang, T. C. Kuo, C.N. Shen, M. Hsiao, P.M. Chiang, F. L. Lu, and J. Lu, 2017, “Elimination of undifferentiated human embryonic stem cells by cardiac glycosides”, Scientific Reports, 7(1), 5289. (SCIE)
  • Hsieh, C.C., I.M. Shyu, W.Y. Liao, T.H. Chen, S.E. Wang, P.C. Lu, P.Y. Lin, Y.B. Chen, W.Y. Mao, H.Y. Han, M. Hsiao, W.B. Yang, W.S. Li, Y.P. Sher, C.N. Shen*, 2017, “Elevation of beta-galactoside alpha 2,6-sialyltransferase 1 modulated in a fructose-responsive manner promotes pancreatic cancer metastasis”, Oncotarget, 8(5), 7691-7709.

Yang, Hwai-I

  • Lai TS, Lee MH, Yang HI, You SL, Lu SN, Wang LY, Yuan Y, L'Italien G, Chien KL, Chen CJ, 2017, “Hepatitis C Viral Load, Genotype, and Increased Risk of Developing End-stage Renal Disease: REVEAL-HCV Study.”, HEPATOLOGY, 66(3), 784-793. (SCIE)
  • Huang CF, Yeh ML, Huang CI, Lin YJ, Tsai PC, Lin ZY, Chan SY, Chen SC, Yang HI, Huang JF, Lu SN, Dai CY, Jen CL, Yuan Y, L'Italien G, Wang LY, Lee MH, Yu ML, Chuang WL, Chen CJ, 2017, “Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance.”, Oncotarget, 8(27), 43925-43933.
  • Chu YJ, Yang HI, Wu HC, Liu J, Wang LY, Lu SN, Lee MH, Jen CL, You SL, Santella RM, Chen CJ, 2017, “Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers.”, International journal of cancer, 141(4), 711-720. (SCIE)
  • Huang YT, Yang HI, 2017, “Causal Mediation Analysis of Survival Outcome with Multiple Mediators.”, EPIDEMIOLOGY, 28(3), 370-378. (SCIE, SSCI) (IF: 5.071; SCI ranking: 8.3%; SSCI ranking: 4.7%)
  • Lee MH, Huang CF, Lai HC, Lin CY, Dai CY, Liu CJ, Wang JH, Huang JF, Su WP, Yang HC, Kee KM, Yeh ML, Chuang PH, Hsu SJ, Huang CI, Kao JT, Chen CC, Chen SH, Jeng WJ, Yang HI, Yuan Y, Lu SN, Sheen IS, Liu CH, Peng CY, Kao JH, Yu ML, Chuang WL, Chen CJ, 2017, “Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.”, Scientific reports, 7(1), 3718. (SCIE)
  • Choijilsuren G, Jhou RS, Chou SF, Chang CJ, Yang HI, Chen YY, Chuang WL, Yu ML, Shih C, 2017, “Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus.”, Scientific reports, 7(1), 14461. (SCIE)
  • Lai TS, Lee MH, Yang HI, You SL, Lu SN, Wang LY, Yuan Y, L'Italien G, Chien KL, Chen CJ, 2017, “High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.”, Kidney international, 92(3), 703-709. (SCIE)
  • Lee MH, Huang YH, Chen HY, Khor CS, Chang YH, Lin YJ, Jen CL, Lu SN, Yang HI, Nishida N, Sugiyama M, Mizokami M, Yuan Y, L'Italien G, Tokunaga K, Chen CJ, 2017, “Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study.”, HEPATOLOGY, 67(2), 651-661. (SCIE)
  • Lin D, Yang HI*, Hoang J, Nguyen MH*, 2017, “Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply.”, Alimentary pharmacology & therapeutics, 45(1), 186-187. (SCIE)
  • Lin D, Yang HI*, Hoang J, Nguyen MH*, 2017, “Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply.”, Alimentary pharmacology & therapeutics, 45(1), 182-183. (SCIE)
  • Wu HC, Yang HI, Wang Q, Chen CJ, Santella RM, 2017, “Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population.”, Carcinogenesis, 38(10), 1021-1028. (SCIE)
  • Huang YW, Yang HI, Wu YT, Hsu TL, Lin TW, Kelly JW, Wong CH, 2017, “Residues Comprising the Enhanced Aromatic Sequon Influence Protein N-Glycosylation Efficiency.”, Journal of the American Chemical Society, 139(37), 12947-12955. (SCIE)
  • Pan WC, Yang HI*, 2017, “Response to RE: Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV)”, JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 109(1), djw185. (SCIE)
  • Liu J, Hu HH, Lee MH, Korenaga M, Jen CL, Batrla-Utermann R, Lu SN, Wang LY, Mizokami M, Chen CJ, Yang HI*, 2017, “Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients.”, Scientific reports, 7(1), 14352. (SCIE)
  • Zeng H, Wu HC, Wang Q, Yang HI, Chen CJ, Santella RM, Shen J, 2017, “Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.”, Anticancer research, 37(2), 637-644. (SCIE)